Risk factor
Limited trading liquidity
Profitability factor
Undervalued vs peers
About
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/E
Target Price
The average target price of 185750.KS is 111500 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell